Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1.400
1.331 stocks
| Empresa | Último precio | Cambio de precio | Capitalización bursátil | ||
|---|---|---|---|---|---|
|
|
|
Abbvie Inc
ABBV
|
$254,49 |
+0%
|
$449,63 B |
|
|
|
Amgen Inc
AMGN
|
$366,29 |
-1,4%
|
$197,69 B |
|
|
|
Gilead Sciences Inc
GILD
|
$134,28 |
-1,5%
|
$166,72 B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$485,65 |
-0,1%
|
$123,26 B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$676,69 |
-0,3%
|
$70,94 B |
|
|
|
argenx SE
ARGX
|
€752 |
+0,2%
|
$53,96 B |
|
|
|
CSL Ltd
CSL
|
AU$123,32 |
+1,1%
|
$41,34 B |
|
|
|
Revolution Medicines Inc
RVMD
|
$186,16 |
+3,9%
|
$39,58 B |
|
|
|
Natera Inc
NTRA
|
$271,39 |
+0,6%
|
$38,87 B |
1.326 resultados ocultos
Crea una cuenta gratuita para desbloquear acceso adicional y mejora para ver todos los resultados
Crear cuenta gratuita
